A
LLY icon

AustralianSuper’s Eli Lilly LLY Stock Holding History

AustralianSuper’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563M Buy
469,702
+192,846
+70% +$197M 2.44% 7
2026
Q1 		$255M Buy
276,856
+110,727
+67% +$112M 1.33% 13
2025
Q4 		$179M Buy
166,129
+120,496
+264% +$115M 0.83% 26
2025
Q3 		$34.8M Buy
45,633
+26,020
+133% +$19.4M 0.16% 106
2025
Q2 		$15.3M Buy
19,613
+7,420
+61% +$5.77M 0.08% 154
2025
Q1 		$10.1M Buy
+12,193
New +$10.1M 0.06% 136
2023
Q3 		– Sell
-2,968
Closed -$1.39M – 263
2023
Q2 		$1.39M Buy
+2,968
New +$1.24M 0.01% 218
2021
Q4 		– Sell
-420,295
Closed -$97.1M – 188
2021
Q3 		$97.1M Sell
420,295
-76,351
-15% -$18.8M 0.62% 38
2021
Q2 		$114M Buy
496,646
+47,898
+11% +$9.62M 0.8% 36
2021
Q1 		$83.8M Buy
448,748
+301,700
+205% +$59M 0.66% 40
2020
Q4 		$24.8M Buy
+147,048
New +$22M 0.19% 68

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AustralianSuper's LLY Position: Q2 2026 in Review

AustralianSuper increased its Eli Lilly (LLY) stake by 70% in Q2 2026, buying an estimated $197M and bringing the position to 469,702 shares worth $563M. The position accounts for 2.44% of the portfolio, ranked #7.

AustralianSuper first reported a position in LLY in Q4 2020 and has held it in 11 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AustralianSuper held 469,702 shares of Eli Lilly worth $563M as of Q2 2026.
  • AustralianSuper bought 192,846 Eli Lilly shares in Q2 2026, an estimated $197M.
  • Eli Lilly made up 2.44% of AustralianSuper's portfolio in Q2 2026, its #7 holding.
  • AustralianSuper first reported a position in Eli Lilly in Q4 2020 and has held it in 11 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AustralianSuper's 13F filing for Q2 2026, filed 12 Aug 2026.